Chargement en cours...
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy
With the use of nucleoside analogs as frontline therapy, the prognosis of hairy cell leukemia (HCL) has improved dramatically. Unfortunately, disease recurrence remains problematic. Eradication of minimal residual disease (MRD) persisting after therapy may further improve outcome. The evolution of a...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109291/ https://ncbi.nlm.nih.gov/pubmed/19814695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428190903142224 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|